Advanced search
Publication Cover
Regenerative Medicine Volume 4, 2009 - Issue 3
Submit an article Journal homepage
3,048
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Induced Pluripotent Stem Cells: An Emerging Technology Platform and the Gartner Hype Cycle

Chris Masona Advanced Centre for Biochemical Engineering, University College London, Roberts Building, Torrington Place, London, WC1E 7JE, UKCorrespondence[email protected] [email protected] www.tandfonline.com
&
Elisa Manzottib Future Medicine Ltd, Unitec House, 2 Albert Place, Finchley Central, London, N3 1QB, UK
Pages 329-331 | Published online: 13 May 2009

Bibliography

  • Nagy A : Regenerative Medicine speaks with Professor Andras Nagy.Regen. Med.4(3) , 351–352 (2009).
  • Nelson TJ , TerzicA: Induced pluripotent stem cells reprogrammed without a trace.Regen. Med.4(3) , 333–335 (2009).
  • Vogel G : Breakthrough of the year.Science322(5909) , 1766–1767 (2008).
  • Mason C : Regenerative Medicine 2.0.Regen. Med.2(1) , 11–18 (2007).
  • Lysaght MJ , HazlehurstAL: Tissue engineering: the end of the beginning.Tissue Eng.10(1–2) , 309–320 (2004).
  • Nerem RM : Tissue engineering: the hope, the hype, and the future.Tissue Eng.12(5) , 1143–1150 (2005).
  • How to grow a human heart. Advances in tissue engineering are bringing it much closer than you think. MIT Technology Review Magazine April 2001.
  • Mason C , DunnillP: The need for a regen industry voice.Regen. Med.3(5) , 621–631 (2008).
  • Fenn J , RaskinoM: Mastering the Hype Cycle. Harvard Business Press, MA, USA (2008).
  • Bock RA : Biotech business strategy – the importance of “Hype”.Bio/Technology4 , 865–867 (1986).
  • Yamanaka S : Pluripotency and nuclear reprogramming.Philos. Trans. R. Soc. Lond. B Biol. Sci.363(1500) , 2079–2087 (2008).
  • Ledford H : In search of a viable business model.Nature Reports Stem Cells doi:10.1038/stemcells.2008.138 (2008) (Epub ahead of print).
  • Gottweis H , MingerS: iPS cells and the politics of promise.Nat. Biotechnol.26(3) , 271–272 (2008).
  • Alper J : Geron gets green light for human trial of ES cell–derived product.Nat. Biotechnol.27 , 213–214 (2009).
  • Templeton S -K: Blind to be cured with stem cells. The Sunday Times 19 April, 2009.

 Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.